Cargando…
Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper
Despite interesting and unique pharmacological properties, levosimendan has not proven a clear superiority to placebo in the patient populations that have been enrolled in the various recent multicenter randomized controlled trials. However, the pharmacodynamic effects of levosimendan are still cons...
Autores principales: | Cholley, Bernard, Levy, Bruno, Fellahi, Jean-Luc, Longrois, Dan, Amour, Julien, Ouattara, Alexandre, Mebazaa, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883606/ https://www.ncbi.nlm.nih.gov/pubmed/31783891 http://dx.doi.org/10.1186/s13054-019-2674-4 |
Ejemplares similares
-
Perioperative hemodynamic optimization: from guidelines to implementation—an experts’ opinion paper
por: Fellahi, Jean-Luc, et al.
Publicado: (2021) -
Overview of the current use of levosimendan in France: a prospective observational cohort study
por: Cholley, Bernard, et al.
Publicado: (2023) -
Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study
por: Cholley, Bernard, et al.
Publicado: (2023) -
Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019) -
In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
por: Yilmaz, Mehmet Birhan, et al.
Publicado: (2011)